More stories

  • in

    Musk’s Starlink ordered to cease operations in Namibia

    Starlink, the satellite unit of SpaceX, operates in several African countries but has faced regulatory challenges in others and resistance from state telecom monopolies.Starlink has submitted an application for a telecommunications service license in Namibia, however the regulator has not issued the license as the application is under review.”Following an investigation, CRAN has established that Starlink is operating a network within Namibia without the required telecommunications license,” CRAN said in a statement.”On 26 November 2024, the Authority issued a cease-and-desist order to Starlink, instructing the company to immediately cease all operations in Namibia.”SpaceX did not immediately respond to a request for comment.The regulator also advised the public not to purchase Starlink terminal equipment or subscribe to its services, as such activities are illegal in Namibia.Its investigators have already confiscated illegal terminals from consumers and have opened criminal cases with the Namibian Police in this regard, it added.Earlier this year, Cameroon ordered the seizure of Starlink equipment at ports as it was not licensed. More

  • in

    How tariffs will disrupt the drinks trade

    Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The spirits business suffered a humdinger of a hangover when the pandemic-era cocktail boom unravelled. Trade wars threaten to make the headache considerably worse. This week US president-elect Donald Trump, who had already mooted tariffs of between 10 and 20 per cent on non-Chinese imports, threatened to put a 25 per cent tariff on all imports from Mexico and Canada on his first day in office. Meanwhile China has slapped duties of up to 39 per cent on EU brandy, in response to levies on Chinese electric vehicles.It is a nasty cocktail for Europe’s drinks companies. Those with tequila brands such as the UK’s Diageo and Italy’s Campari are exposed to US-Mexico tariffs. Diageo also faces higher tariffs on Crown Royal whisky shipped from Canada to the US. Those companies along with Rémy Cointreau and Pernod Ricard, both based in France, would also be hit by tariffs on imports from the EU and UK. For some, the impact would be hard to swallow. Imposing a 25 per cent tariff on US imports from Canada and Mexico and 10 per cent on those from the EU and UK would cut earnings per share for Pernod, Campari, Diageo and Rémy by 3 per cent, 8 per cent, 8 per cent and 19 per cent respectively, according to Deutsche Bank.It might not happen. In 2019, Trump’s tariff threats roiled the market for months but were eventually watered down to cover just single malt scotch and Irish whiskey made in the UK, says Ed Mundy of Jefferies. The industry is lobbying hard on the impact on consumers and hospitality job losses.Chinese tariffs are already proving disruptive. Hennessy, owned by French luxury group LVMH, briefly considered bottling its brandy in China to avoid import tariffs. But it suspended the plan after hundreds of workers went on strike. Rémy Cointreau is particularly exposed. On Thursday it said the proposed US 10 per cent tariff “is not going to kill us for sure” but acknowledged that the Chinese tariffs were a concern. It plans to cut costs and adjust prices to mitigate the impact, though weak demand will make it hard to pass on extra costs.Even before Rémy feels the hit from Chinese tariffs, its sales this year will drop by more than analysts expected. There are, however, some early signs of stabilisation in the US market. Thursday’s 3 per cent share price rise is a sign that some investors think the fall in the shares — down by 70 per cent since 2021 — has gone far enough. If tariffs are watered down, investors can start to look ahead to a time when the party gets going again. For now, however, the threat of higher duties is a big dampener on high spirits. vanessa.houlder@ft.com More

  • in

    Budget woes put French borrowing costs equal with crisis-scarred Greece

    LONDON (Reuters) – French borrowing costs effectively matched those of Greece on Thursday for the first time, as Michel Barnier’s government teetered on the brink of collapse, underlining a dramatic shift in how lenders view the creditworthiness of euro zone members.Far-right and leftist opposition parties have been threatening to bring down Barnier’s government over its budget that includes 60 billion euros ($63 billion) in tax hikes and spending cuts.Bond investors worry that the collapse of the government would mean any effort to cut borrowing is jettisoned.”A no-confidence vote would reset the progress made with the current budget proposal and trigger a new period of political limbo,” said Michiel Tukker, senior European rates strategist at lender ING.In the middle of the euro zone sovereign crisis in 2012, Greece’s borrowing costs, as measured by its 10-year bond yield, shot to more than 37 percentage points above those in France, as Greece looked destined to default on its debts.Fast forward 12-1/2 years and Greek debt on Thursday morning traded within 0.02 percentage points of France at around 3%.France’s rising debt levels have been slowly eroding its advantages in the bond market for years. Then, the risk premium investors demand to buy French debt compared to its neighbours shot higher in June when President Emmanuel Macron called a snap election that resulted in a fragile hung parliament.Meanwhile, the countries once at the centre of the 2012 crisis and labeled the PIGS – Portugal, Italy, Greece and Spain – have cut their debt levels and become more attractive to bond investors.Greek public debt was already running at 100% of GDP before the euro zone crisis and surged to more than 200% as COVID-19 hit in 2020. But it has since fallen to around 160% of GDP and economists expect it to continue to fall. French debt is historically elevated at 112% of GDP and rising. The state has spent heavily in response to the shocks of COVID-19 and the Ukraine war, while tax receipts have lagged expectations. “Even if the government did achieve its planned consolidation, France would still have a pretty elevated budget deficit,” said Max Kitson, rates strategist at Barclays (LON:BARC).”If you look at Greece’s debt-to-GDP profile, you have a downwards trajectory which contrasts with France’s upwards trajectory.”Similar efforts to rein in debt – as well as years of bond purchases by the European Central Bank – in Ireland, Portugal and Spain have seen those countries’ borrowing costs fall below those of France.On the plus side for France, its bond yields have not risen sharply in absolute terms and are in fact down around 16 basis points since the start of the month.Friday evening will prove a test, when S&P Global Ratings will update its assessment of France, after Fitch and Moody’s (NYSE:MCO) downgraded their outlooks on the country last month. More

  • in

    Britain pledges $2.5 billion to World Bank fund for poor nations

    The investment will fund projects promoting economic growth, tackling poverty and addressing the impacts of climate change, the government said in a statement.The IDA fund, which mainly provides grants and very low interest loans to the poorest countries, is replenished every three years, and a pledging conference is scheduled for Dec. 5-6 in Seoul.World Bank President Ajay Banga is aiming for a record amount exceeding the $93 billion refunding in December 2021, amid rising demands from poor nations that are struggling with crushing debts, climate disasters, conflict and other pressures.U.S. President Joe Biden pledged a $4 billion U.S. contribution to the IDA fund last week.Britain used to devote 0.7% of its gross national income to overseas development aid, but the previous Conservative government cut that level to 0.5% in 2021 due to the impact of the COVID-19 pandemic.Prime Minister Keir Starmer’s Labour government, in office since July, has pledged to restore the aid budget to the previous level but has not set a timeline for it.($1 = 0.7897 pounds) More

  • in

    The path to ‘Made in India’

    $1 for 4 weeksThen $75 per month. Complete digital access to quality FT journalism. Cancel anytime during your trial.What’s included Global news & analysisExpert opinionFT App on Android & iOSFT Edit appFirstFT: the day’s biggest stories20+ curated newslettersFollow topics & set alerts with myFTFT Videos & Podcasts20 monthly gift articles to shareLex: FT’s flagship investment column15+ Premium newsletters by leading expertsFT Digital Edition: our digitised print edition More

  • in

    These economists say artificial intelligence can narrow U.S. deficits by improving health care

    The potential positive shock of AI on the U.S.’s fiscal health could help lower the fiscal deficit, according to a study from the Brookings Institution.
    The report forecasts AI could lower the U.S. budget deficit by 1.5% of GDP by 2044.
    The incoming Trump administration raises questions as to how AI might be implemented in delivering health care services.

    Just_super | E+ | Getty Images

    Can artificial intelligence be so transformative as to solve one of the U.S. economy’s biggest problems: its skyrocketing fiscal deficit? According to three economists at the Brookings Institution, the answer is yes — AI could prove a positive “critical shock” for the country’s fiscal health. 
    A working paper released last month by the Center on Regulation and Markets at Brookings projects that under the most optimistic scenario, AI could reduce the annual U.S. budget deficit by as much as 1.5% of gross domestic product by 2044, or about $900 billion in nominal terms, lowering annual budget deficits by roughly one fifth at the end of the 20-year span.

    “The use of AI presents the rare — possibly unique — opportunity to expand access to health care information and services while simultaneously reducing the burden on the conventional health care system,” the paper’s authors, Ben Harris, Neil Mehotra and Eric So, wrote.
    While the authors name various channels through which AI can increase productivity, they highlight AI’s potential to dramatically improve health care services and public health. 
    Not only could AI make American health care more efficient, it might also “democratize” access to the system by giving people more options for preventative medical care — “changing the ‘who’ and ‘where’ of health care,” the economists wrote.
    AI could ease deficit pressure
    The economic impacts of a more efficient health care system, and giving individuals more paths to manage their own health, could ease pressure on the government’s yawning fiscal deficit, which topped $1.8 trillion in the fiscal year ended Sept. 30. The national debt stands at $36 trillion.
    But adopting AI in health care services isn’t a sure thing. Plenty of impediments stand in the way of widely implementing AI, largely tied to regulation and incentives.

    Economists’ outlook on AI and health care is “a mix of enthusiasm and despair,” said Ajay Agrawal, a professor at the University of Toronto’s Rotman School of Management ,where he researches the economics of artificial intelligence.
    “Enthusiasm because there’s probably no sector that stands to benefit more from AI than health care. … But there’s friction due to regulation, due to incentives —  because of the way things are structured and how people are paid for things — and friction due to the associated risks and liabilities,” Agrawal said. 
    “So yes, there’s lots of implementation challenges, and at the same time, the prize for succeeding at this is very big,” Agrawal said. 
    Health care and the deficit
    The federal government spent an estimated $1.8 trillion on health insurance in 2023, or around 7% of GDP, according to the Congressional Budget Office. From 2024 to 2033, the CBO forecasts federal subsidies for health care will total $25 trillion, or 8.3% of GDP. 
    The problem is that so much health care spending in the U.S. isn’t tied to treatment or patient outcomes. Instead, about a quarter of all spending, public and private, is estimated to go toward administrative functions.
    “Nearly every industry in the U.S. has experienced substantial improvements in productivity over the last 50 years, with 1 major exception: health care,” according to a report by McKinsey analysts. 
    This is one area where AI could improve operations, according to the Brookings Institution economists. Basic tasks such as appointment scheduling can be automated, while tasks such as patient flow management and preliminary data analysis can also be done by AI programs.
    While the three economists acknowledge that the impact of AI on federal spending is still “highly uncertain,” the coauthors believe it could ultimately be more transformative for the economy than past technological leaps, such as the use of personal computers in the 1990s. The current AI shock “feels different. This isn’t your typical technological shock,” Harris told CNBC.
    AI is affecting “how people receive health care,” how the drug industry discovers new products and how researchers make medicine more precise, Harris said.
    Disease and death rates
    In particular, Harris underscored AI’s impact not just on productivity, but also its potential to transform the cost of care and the rates of illness, disease and death. 
    “Such changes could have profound impacts on Social Security and public health program outlays,” he and his coauthors wrote.
    To be sure, there is also the potential that AI advancements could counterintuitively increase federal spending if the average lifespan increases as a result of the technology. Not only could improved technology lead people to seek more medical care, longer lifespans might also result in a larger retired population.
    But the Brookings paper takes a more optimistic tack, predicting one of AI’s largest benefits will result from accelerating the efficacy of preventative care and disease detection. This will create a healthier population that will need less medical intervention, the authors wrote — and might also increase labor force participation rates if a healthier workforce stays employed for more years.
    “AI’s ability to improve diagnostic accuracy can not only improve patient outcomes but also reduce wasteful spending on inappropriate treatments,” the economists said. “From a more optimistic perspective, existing AI systems may lower expenditures on all health spending, including Medicare, with cost reductions occurring through several channels—with personalized medicine being a prominent example.”
    Evaluating whether AI can ultimately translate into a positive or negative shock on fiscal policy will depend on what stage of the age distribution it affects, Agrawal said. Whether AI is “having its bigger impact on retired people, or around working people,” will answer how the numbers play out, Agrawal said. 
    AI proliferating already
    So far, diagnostics has shown the most advances and greatest potential in applying AI in health care. Agrawal cited AI’s influence throughout almost all the steps of diagnostic care, from receiving input data, medical imagery such as X-rays and MRIs, as well as doctor notes, charts. 
    “In almost every area of diagnosis, AI has, in some cases, already demonstrated what they call ‘superhuman performance’ — better than than most docs,” Agrawal said. 
    AI has also shown “significant promise” in better optimizing treatment plans for patients through data analysis. Machine intelligence can develop more effective and less costly plans for individual patients, according to the authors of the paper. 
    Agrawal believes it’s too early to say whether public or private health systems will take better advantage of AI. In the U.S., private insurers have generally been more keen on AI technology associated with preventative treatment, he said. There’s been less interest in using AI in diagnostic applications, possibly that might lead to a rise in cases and more treatment, he said. 
    “There aren’t clear economic incentives for the private sector to [implement] that,” said Agrawal. “In the public sector, even though there are incentives, there are a lot of frictions associated with privacy on the data side.” 
    He believes public-private partnerships will be key in driving the rollout of AI across health care. 
    The public health care sector “will need very strong incentives in order to drive change, because otherwise, everybody is in their routine. There’s a lot of resistance to change,” Agrawal said. 
    “So to get over that resistance, you need a very strong motivator, and the private sector generally provides a much stronger motivator, either because the users are trying to reduce cost, or the creators of the technology are trying to generate profit,” he continued. 
    Large tech companies have already pushed forward in developing large language models specifically for health care services. Google’s AI system, Articulate Medical Intelligence Explore (AMIE), mimics diagnostic dialogue. Its Med-Gemini platform uses AI to aid in diagnosis, treatment planning and clinical decision support. Amazon and Microsoft have their own projects underway to expand the application of AI programs in health services.
    Outlook under Trump 
    President-elect Donald Trump’s second term could alter the rollout of AI in health care, and ultimately, its economic impact. Trump has vowed to reduce government spending and formed an outside panel called the Department of Government Efficiency designed to “dismantle Government Bureaucracy, slash excess regulations, cut wasteful expenditures, and restructure Federal Agencies.” Public health funding is one area that could reduced funding, frustrating the ability to roll out AI applications.  
    “Now, it is possible that if you do see a retreat in the federal government’s role in providing health care to people, that more efficient AI could help compensate for the cost of that retreat,” said Harris. “If AI means that each dollar goes farther, then I think we’ve timed everything in a sort of lucky way.” 
    There’s also the chance that rolling back regulations under a second Trump administration could expedite the implementation of AI across health care. 
    “Many people are fearful of reducing regulation because they don’t want technologies that are immature to be brought into the health care system and harm people,” Agrawal said. “And that’s a very legitimate concern. But very often what they fail to also put into their equation is the harm we’re causing people by not bringing” in new technologies, he added. 
    “Some areas need a lot more technical development, but there are some domains in diagnosis that are already ready to go, and it’s just regulation that’s preventing them from being used,” Agrawal said.  More

  • in

    German inflation unchanged at 2.4% in November

    BERLIN (Reuters) – German inflation remained flat in November despite expectations of a second consecutive increase interrupting the downward trend in Europe’s troubled largest economy.Inflation stayed at 2.4%, the federal statistics office said on Thursday.Analysts polled by Reuters had expected a reading of 2.6% this month, after German consumer prices, harmonised to compare with other European Union countries, had risen by 2.4% year-on-year in October.Core inflation, which excludes volatile food and energy prices, was at 3.0% in November. The German data comes ahead of the euro zone inflation release on Friday. Harmonised inflation in the euro zone is expected to rise to 2.3% in November from 2.0% the previous month, according to economists polled by Reuters.Investors are watching the inflation data for Germany and the euro zone as a whole to gauge the next steps of the European Central Bank.The ECB is expected to cut interest rates further at its upcoming meetings, but the scale and speed of that course is unclear. More

  • in

    Brazil’s Haddad says income tax reform to be neutral, take effect in 2026

    BRASILIA (Reuters) – Brazilian Finance Minister Fernando Haddad said on Thursday that a reform proposed by the government to increase income tax exemptions for the middle-class will be fiscally neutral and analyzed by Congress in time for it to take effect in 2026.After weeks of delays, Brazil on Wednesday announced a package to contain mandatory spending, accompanied by an unexpected income tax reform aimed at easing the burden on the middle-class to mitigate potential negative public backlash.Haddad told a press conference that the move to increase the exemption threshold for those earning up to 5,000 reais a month had an estimated 35 billion real ($5.89 billion) fiscal impact, which would be fully neutralized by compensatory measures. The government said the compensation would come from setting a higher effective tax rate for the wealthiest. According to Haddad, those earning more than 600,000 reais per year will face an effective income tax rate of 10%.The current effective tax rate is 4.2% for the top 1% of earners and 1.75% for the top 0.01%, government figures showed.When questioned about introducing the measure now despite its expected implementation only in 2026, Haddad said the decision was to “finalize all measures this year” to make “our project clear”.He had previously said the issue would only be addressed next year.MARKET TURMOILBefore the official announcement, reports of an increase in the income tax exemption from the current 2,824 reais soured market sentiment. The currency plummeted to its weakest level on record, while interest rate futures surged.”The fiscal tightening measures failed to live up to expectations and reinforce the idea that political commitment to stabilizing the public finances is lacking,” Capital Economics’ deputy chief emerging markets economist Jason Tuvey said.The real weakened past 5.98 per dollar in spot trading on Thursday.Haddad said the U.S. dollar had been strengthening globally, and told the press conference that inflation in Brazil is expected to end the year within or very close to the official target range of 1.5% to 4.5%.The government also outlined that the mandatory spending control package announced on Wednesday is projected to generate a fiscal impact of 327 billion reais between 2025 and 2030.The measures, which have yet to be formalized and voted by Congress, also include tighter restrictions on the BPC social benefit, aimed at assisting the elderly and disabled, and enhanced oversight of the Bolsa Familia welfare program.($1 = 5.9377 reais) More